fluorouracil has been researched along with nobiletin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Ahn, KS; Cho, M; Cho, SK; Moon, JY | 1 |
| Feng, S; Liu, L; Ma, W; Xie, Y; Yao, X; Yuan, Z | 1 |
3 other study(ies) available for fluorouracil and nobiletin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Nobiletin induces apoptosis and potentiates the effects of the anticancer drug 5-fluorouracil in p53-mutated SNU-16 human gastric cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Caspase 9; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Flavones; Fluorouracil; G1 Phase Cell Cycle Checkpoints; Humans; Mutation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2013 |
Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells.
Topics: Adsorption; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Cycle; Cell Line, Tumor; Docetaxel; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Flavones; Fluorouracil; Humans; Intracellular Space; Models, Biological; Molecular Docking Simulation; Paclitaxel; Rhodamine 123; Signal Transduction; Taxoids; Treatment Outcome | 2015 |